Up and Down the Ladder: Job Changes.. the latest comings and goings.. statnews.com/pharmalot/20... #pharma #biotech #jobs #Genentech #Novartis #BioMarin #Roche
@pharmalot.bsky.social
@pharmalot.bsky.socialUp and Down the Ladder: Job Changes.. the latest comings and goings.. statnews.com/pharmalot/20... #pharma #biotech #jobs #Genentech #Novartis #BioMarin #Roche
@longevitytech.bsky.socialNovartis’ President of Biomedical Research, Fiona Marshall, on what it would take for big pharma to go all in on longevity.
Link as first comment.
#longevity #Novartis #biomedicalresearch #pharma #FionaMarshall
@pharmaphorum.bsky.social#Novartis' oral #BTKinhibitor #Rhapsido has had its label expanded in the #US to include a second indication, #symptomaticdermographism (SD), which causes #chronichives.
@narrowit.bsky.socialNovartis Licenses Abogen RNA Drug in $575 Million Upfront Deal Novartis agreed to pay Abogen $575 million upfront for worldwide rights to ABO2203 and options...
https://www.narrowit.com/news/abogen-novartis-rna-license-575-million-2026-10-04
#AbogenBiosciences #Novartis #ABO2203 #MrnaTherapeutics
@quartzmedia.bsky.social
@eueconomics.bsky.social
@eu-economics.wsocial.eu
@pharmaphorum.bsky.social#Novartis has added a #Tcellengager (TCE) developed by China's #AbogenBiosciences for #autoimmunedisorders in a deal that could be worth over $7.5 billion.
@quartzmedia.bsky.social
@newsen.bsky.socialAbogen's Strategic Partnership with Novartis for Innovative mRNA Therapeutics #China #Suzhou #Novartis #mRNA_Therapeutics #Abogen
@newsen.bsky.socialAbogen and Novartis Forge Strategic Alliance for Innovative mRNA Therapies #China #Suzhou #Novartis #mRNA_Therapy #Abogen_Biosciences
@kensbookinfo.bsky.socialCafePharma: Is #Novartis the worst of the worst within big pharma? - https://kensbookinfo.blogspot.com/p/end-of-line.html#CafePharma Evening Standard: Slowest #UK population growth outside pandemic since 1998 - https://kensbookinfo.blogspot.com/p/uk.html#UKNews17945366
@4040rec.bsky.social@newsen.bsky.social@newsen.bsky.socialCAS and Novartis Collaborate to Revolutionize AI-Driven Reaction Informatics #USA #Columbus #CAS #Novartis #AI_Collaboration
@newsen.bsky.social@newsen.bsky.social@newsen.bsky.socialCAS Partners with Novartis to Enhance AI-Ready Reaction Informatics and Data Accessibility #USA #Columbus #CAS #Novartis #reaction_data
@top10grid.bsky.socialNo. 1 in technology: AstraZeneca. Top 10 European Pharmaceutical Tech Companies. https://top10grid.com/top-10-european-pharmaceutical-tech-companies?utm_source=bluesky&utm_medium=social&utm_campaign=video-distribution #astrazeneca #novartis #roche
@pharmalot.bsky.social